republic-os/legislation/us/states/ca/20232024/sb-19.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Fentanyl Misuse and Overdose Prevention Task Force.	Existing law, the California Uniform Controlled Substances Act, classifies controlled substances into 5 schedules and places the greatest restrictions and penalties on the use of those substances placed in Schedule I. The act classifies the drug fentanyl in Schedule II. Existing law prohibits a person from possessing for sale or purchasing for purposes of sale, specified controlled substances, including fentanyl, and provides for imprisonment in a county jail for 2, 3, or 4 years for a violation of this provision. Existing law also requires a local health officer to assume that the fentanyl manufacturing process has led to some degree of chemical contamination and take action, as prescribed, if a fentanyl laboratory activity has taken place at a property.	us/states/ca	California Legislature	20232024	SB 19	California SB 19 (20232024)	bill	Fentanyl Misuse and Overdose Prevention Task Force	enacted	Seyarto	8	31	9	2022-12-05	2023-10-13	openstates	ocd-bill/2fd39f6d-4b34-409f-b67e-6260360f538f	http://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=202320240SB19	1a727461d573df28f83c10ea45c7ec5f63592fae62fae021fee941c8cbf89a44	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-ca

California SB 19 (20232024) — Fentanyl Misuse and Overdose Prevention Task Force.

Existing law, the California Uniform Controlled Substances Act, classifies controlled substances into 5 schedules and places the greatest restrictions and penalties on the use of those substances placed in Schedule I. The act classifies the drug fentanyl in Schedule II. Existing law prohibits a person from possessing for sale or purchasing for purposes of sale, specified controlled substances, including fentanyl, and provides for imprisonment in a county jail for 2, 3, or 4 years for a violation of this provision. Existing law also requires a local health officer to assume that the fentanyl manufacturing process has led to some degree of chemical contamination and take action, as prescribed, if a fentanyl laboratory activity has taken place at a property.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. 12/05/22 - Introduced (filed) — source
2. 03/07/23 - Amended Senate (committee substitute) — source
3. 06/22/23 - Amended Assembly (committee substitute) — source
4. 09/01/23 - Amended Assembly (committee substitute) — source
5. 09/07/23 - Amended Assembly (committee substitute) — source
6. 10/13/23 - Chaptered (committee substitute) — source
7. SB19 (committee substitute) — source
8. 09/18/23 - Enrolled (enrolled) — source

Votes

• Placed on suspense file — 7–0 (pass) · upper
• SB 19 Seyarto Senate Third Reading By Bains — 79–0 (pass) · lower
• Do pass as amended, and be re-referred to the Committee on [Public Safety] with recommendation: To Consent Calendar — 14–0 (pass) · lower
• Do pass and be re-referred to the Committee on [Appropriations] — 8–0 (pass) · lower
• Do pass as amended. — 15–0 (pass) · lower
• Unfinished Business SB19 Seyarto et al. Concurrence — 40–0 (pass) · upper
• Do pass — 7–0 (pass) · upper
• Special Consent SB19 Seyarto et al. — 40–0 (pass) · upper
• Do pass, but first be re-referred to the Committee on [Appropriations] — 4–0 (pass) · upper

Sponsors

• Seyarto — primary (person)
• Bains — principal coauthor (person)
• Chen — coauthor (person)
• Dodd — coauthor (person)
• Gallagher — coauthor (person)
• Jones — coauthor (person)
• Nguyen — coauthor (person)
• Ochoa Bogh — coauthor (person)
• Umberg — coauthor (person)
• Wilk — coauthor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2022-12-05 Introduced. Read first time. To Com. on RLS. for assignment. To print. introduction, reading-1
• 2022-12-06 From printer. May be acted upon on or after January 5.
• 2023-01-18 Referred to Com. on PUB S. referral-committee
• 2023-02-23 Set for hearing March 14.
• 2023-03-07 From committee with author's amendments. Read second time and amended. Re-referred to Com. on PUB S. amendment-passage, committee-passage, reading-1, reading-2, referral-committee
• 2023-03-14 From committee: Do pass and re-refer to Com. on APPR. (Ayes 4. Noes 0. Page 340.) (March 14). Re-referred to Com. on APPR. committee-passage, committee-passage-favorable, referral-committee
• 2023-03-28 Set for hearing April 10.
• 2023-04-10 April 10 hearing: Placed on APPR suspense file.
• 2023-05-12 Set for hearing May 18.
• 2023-05-18 From committee: Do pass. (Ayes 7. Noes 0. Page 1157.) (May 18). committee-passage, committee-passage-favorable
• 2023-05-18 Read second time. Ordered to third reading. reading-1, reading-2
• 2023-05-23 Ordered to special consent calendar.
• 2023-05-25 Read third time. Passed. (Ayes 40. Noes 0. Page 1295.) Ordered to the Assembly. passage, reading-1, reading-3
• 2023-05-25 In Assembly. Read first time. Held at Desk. reading-1
• 2023-06-08 Referred to Coms. on HEALTH and PUB. S. referral-committee
• 2023-06-21 From committee: Do pass as amended and re-refer to Com. on PUB. S. with recommendation: To consent calendar. (Ayes 14. Noes 0.) (June 20). amendment-passage, committee-passage, committee-passage-favorable
• 2023-06-22 Read second time and amended. Re-referred to Com. on PUB. S. amendment-passage, reading-1, reading-2, referral-committee
• 2023-07-12 From committee: Do pass and re-refer to Com. on APPR. (Ayes 8. Noes 0.) (July 11). Re-referred to Com. on APPR. committee-passage, committee-passage-favorable, referral-committee
• 2023-08-16 August 16 set for first hearing. Placed on suspense file.
• 2023-09-01 From committee: Do pass as amended. (Ayes 15. Noes 0.) (September 1). amendment-passage, committee-passage, committee-passage-favorable
• 2023-09-01 Read second time and amended. Ordered to second reading. amendment-passage, reading-1, reading-2
• 2023-09-05 Read second time. Ordered to third reading. reading-1, reading-2
• 2023-09-07 Assembly Rule 69 suspended.
• 2023-09-07 Read third time and amended. amendment-passage, reading-1, reading-3
• 2023-09-07 Ordered to third reading.
• 2023-09-13 Read third time. Passed. (Ayes 79. Noes 0. Page 3393.) Ordered to the Senate. passage, reading-1, reading-3
• 2023-09-13 In Senate. Concurrence in Assembly amendments pending.
• 2023-09-14 Assembly amendments concurred in. (Ayes 40. Noes 0. Page 2797.) Ordered to engrossing and enrolling. amendment-passage, committee-passage-favorable
• 2023-09-21 Enrolled and presented to the Governor at 4 p.m.
• 2023-10-13 Approved by the Governor. executive-signature
• 2023-10-13 Chaptered by Secretary of State. Chapter 857, Statutes of 2023. became-law

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/2fd39f6d-4b34-409f-b67e-6260360f538f. Confidence: reported (aggregated from official California legislature records).